Skip to main content
2026 CRT Conference Main banner

CRT 2026

Morning Symposium

Session:: Morning Symposium | FFRangio: At the Edge of a New Dawn [CME] – Supported Through an Educational Grant by CathWorks

Case Discussion with Expert Faculty

Sunday, March 8, 2026
7:50 AM - 8:00 AM EST
Location: Lincoln

    Moderator(s)

  • William F. Fearon, MD

    Professor of Medicine Director, Interventional Cardiology
    Stanford University School of Medicine
    Stanford, California, United States

    Disclosure(s): Abbott Cardiovascular Systems: Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Grant/Research Support (Ongoing)

  • Evan Shlofmitz, DO

    Director of Intravascular Imaging
    St. Francis Hospital - The Heart Center
    Roslyn, New York, United States

    Disclosure(s): ABBOTT VASCULAR, ACIST MEDICAL, BOSTON SCIENTIFIC, CHIESI, HEARTFLOW, GENTUITY, MEDTRONIC, PHILIPS, RADIACTION, SHOCKWAVE MEDICAL, TERUMO: Consulting Fees (e.g., advisory boards) (Ongoing); AMGEN, NOVO NORDISK: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

    • Panel Discussant(s)

  • Karim Al-Azizi, MD, FACC, FSCAI, FESC

    Medical Director, Cardiac Catheterization Laboratories
    The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
    Frisco, Texas, United States

    Disclosure information not submitted.

  • MP

    Megha Prasad, MD

    Assistant professor
    Columbia University

    Disclosure information not submitted.

  • Yader Sandoval, MD

    Interventional Cardiologist, Adjunct Associate Professor Of Medicine
    Minneapolis Heart Institute
    Edina, Minnesota, United States

    Disclosure information not submitted.

  • Eric A. Secemsky, MD, MSc

    Director of Vascular Intervention
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Doosup Shin, MD

    Interventional Cardiologist
    St Francis Hospital & Heart Center
    Roslyn, New York, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
William F. Fearon, MD: Abbott Cardiovascular Systems: Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Grant/Research Support (Ongoing)
Evan Shlofmitz, DO: ABBOTT VASCULAR, ACIST MEDICAL, BOSTON SCIENTIFIC, CHIESI, HEARTFLOW, GENTUITY, MEDTRONIC, PHILIPS, RADIACTION, SHOCKWAVE MEDICAL, TERUMO: Consulting Fees (e.g., advisory boards) (Ongoing); AMGEN, NOVO NORDISK: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Eric A. Secemsky, MD, MSc: Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)
Doosup Shin, MD: No financial relationships to disclose